Lataa...
Reversing multidrug resistance by tyrosine kinase inhibitors
Recently, a large number of tyrosine kinase inhibitors (TKIs) have been developed as anticancer agents. These TKIs can specifically and selectively inhibit tumor cell growth and metastasis by targeting various tyrosine kinases and thereby interfering with cellular signaling pathways. The therapeutic...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Sun Yat-sen University Cancer Center
2012
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3777484/ https://ncbi.nlm.nih.gov/pubmed/22237041 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5732/cjc.011.10315 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|